WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: Previous page | 1,2,3,4,5,6,7,8,9,10,11

References

Statement on use of cotrimoxazole prophylaxis Who should get cotrimoxazole: How long should cotrimoxazole be given: Under what circumstances should cotrimoxazole be discontinued: What doses of cotrimoxazole should be used? What follow-up is required? Other operational issues Patient information Policy and programme information Monitoring and evaluation References

1. Provisional WHO/Unaids Secretariat Recommendations Unaids On The Use Of Cotrimoxazole Prophylaxis In Adults And Children Living With HIV/Aids In Africa, accessible at: http://www.unaids.org/EN/other/functionalities/Search.asp

2. Co-trimoxazole as prophylaxis against opportunistic infections as HIV-infected Zambian children (CHAP): a chap a double-blind randomized placebo-controlled trial. Chintu C, GJ Bhat, AS Walker, V Mulenga, F Sinyinza, L Farrelly, Kagangson, A Zumla, Gillespie, A Nunn, D M Gibb Lancet 2004;364: 1865-71

WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: 1,2,3,4,5,6,7,8,9,10,11